|
Title
|
Published
|
Price
|
|
Biotechnology Sector
By: First Research, Inc.
The US biotechnology industry includes about 1,500 companies with combined annual revenue of about $70 billion. Major companies include Amgen, Biogen Idec, Genentech (owned by Switzerland-based Roche), Genzyme, Life Technologies, and Monsanto. Because many drugs
|
more...
Search inside this report
|
11/16/2009
|
$129.00
|
|
Genetic Engineering
By: Global Industry Analysts
The global outlook series on Genetic Engineering provides a collection of market briefs and concise summaries of research findings. The report offers a bird’s eye view of the industry, highlights latest developments, and discusses demand
|
more...
|
10/1/2009
|
$950.00
|
|
The World Market for Biosimilars and the Potential for US Follow-on Biologics
By: Kalorama Information
Biosimilars, or generic biologic drugs, are marketed around the world but still restricted in the U.S. This may soon change, and Kalorama Information has released this timely study of the market in Europe and
|
more...
Search inside this report
|
8/1/2009
|
$3,700.00
|
|
Stem Cell Markets
By: Trimark Publications
A stem cell is an extraordinary type of cell that has the ability to self-renew for long periods of time and to differentiate into specialized cells under appropriate physiological or experimental conditions. Traditionally, stem cells
|
more...
|
6/1/2009
|
$3,400.00
|
|
The 2009 Report on Gene Expression Services: World Market Segmentation by City
By: Icon Group International, Inc.
This report was created for global strategic planners who cannot be content with traditional methods of segmenting world markets. With the advent of a “borderless world”, cities become a more important criteria in prioritizing markets,
|
more...
Search inside this report
|
1/5/2009
|
$795.00
|
|
The 2009-2014 Outlook for Gene Expression Services in the United States
By: Icon Group International, Inc.
This econometric study covers the latent demand outlook for gene expression services across the states and cities of the United States. Latent demand (in millions of U.S. dollars), or potential industry earnings (P.I.E.) estimates are
|
more...
Search inside this report
|
12/2/2008
|
$495.00
|
|
The 2009-2014 Outlook for Gene Expression Services in India
By: Icon Group International, Inc.
This econometric study covers the latent demand outlook for gene expression services across the states, union territories and cities of India. Latent demand (in millions of U.S. dollars), or potential industry earnings (P.I.E.) estimates are
|
more...
Search inside this report
|
12/2/2008
|
$495.00
|
|
The 2009-2014 Outlook for Gene Expression Services in Greater China
By: Icon Group International, Inc.
This econometric study covers the latent demand outlook for gene expression services across the regions of Greater China, including provinces, autonomous regions (Guangxi, Nei Mongol, Ningxia, Xinjiang, Xizang - Tibet), municipalities (Beijing, Chongqing, Shanghai, and
|
more...
Search inside this report
|
12/2/2008
|
$495.00
|
|
The 2009-2014 Outlook for Gene Expression Services in Japan
By: Icon Group International, Inc.
This econometric study covers the latent demand outlook for gene expression services across the prefectures and cities of Japan. Latent demand (in millions of U.S. dollars), or potential industry earnings (P.I.E.) estimates are given across
|
more...
Search inside this report
|
12/2/2008
|
$495.00
|
|
Biopharmaceutical Expression Systems and Genetic Engineering Technology
By: BioPlan Associates, Inc.
Comprehensive Review of Expression
Systems for Biopharmaceutical
Manufacturing
New biopharmaceutical expression systems are beginning to revolutionize
the industry! Lower costs and efficiencies of newer expression systems are
driving these changes. Our new study provides you
|
more...
|
11/1/2008
|
$645.00
|
|
The 2009-2014 World Outlook for Gene Expression Services
By: Icon Group International, Inc.
This econometric study covers the world outlook for gene expression services across more than 200 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country
|
more...
Search inside this report
|
9/20/2008
|
$795.00
|
|
Stem Cell Technology: Current Applications and Future Directions
By: BCC Research
Analyzes adult and embryonic stem cell technology, applications (current and future), as well as the impact of stem cell focused products and services on healthcare markets and beyond. Provides quantitative market
|
more...
Search inside this report
|
7/1/2008
|
$4,850.00
|
|
Stem Cells: Worldwide Markets for Transplantation, Cord Blood Banking and Drug Development
By: Kalorama Information
With their ability to differentiate and become an ongoing source of cells that make up critical tissues and organs, stem cells have potential for new regenerative therapies and as new research tools for drug developers
|
more...
Buy by the section | Search inside this report
|
3/1/2008
|
$3,995.00
|
|
Cell Therapy Markets
By: Trimark Publications
Cell therapy technologies and methods have already started to play an important role in the practice of medicine. Hematopoietic stem cell transplantation is replacing the old fashioned bone marrow transplants. Cell therapy is bound to
|
more...
|
7/1/2007
|
$3,400.00
|
|
Developments in Stem Cell Research (Technical Insights)
By: Frost & Sullivan
The Frost & Sullivan research service titled Developments in Stem Cell Research provides an overview of the advances in stem cell technologies and covers at length on the drivers and challenges that are associated with
|
more...
|
3/31/2007
|
$6,000.00
|
|
Stem Cell - Analysis and Market Forecasts, 2006-2016
By: RRY Publications
Sales of stem cell products in the United States reached $16.4 million in 2006 and are expected to surpass $35 million in 2007, according to author Robin R. Young, a medical industry analyst who has
|
more...
|
3/1/2007
|
$2,995.00
|
|
Tissue Engineering & Stem Cell Technology Report 2007
By: Visiongain
The market potential of this technology is so huge that revenues may be in excess of $10 billion by 2013. This is a market that you should be part of - NOW!! With a
|
more...
|
2/28/2007
|
$2,210.00
|
|
Hitting the Bull's-Eye with Your Eyes Closed: The Stem Cell Magic Bullet
By: IDC
This Health Industry Insights Perspective describes analyst perspectives on emerging efforts to develop stem cells as therapeutic solutions. Despite only nascent understanding of stem cells and how they work, research is advancing in several
|
more...
Search inside this report
|
12/22/2006
|
$500.00
|
|
New Options for Treating Neurological Disease: Stem Cell Therapy
By: Decision Resources
Stem cell therapy development is challenged by controversy, intellectual property issues, and a
high failure rate. Despite these challenges, stem cell therapy presents some of the most promising
options for hard-to-treat and highly degenerative neurological
|
more...
|
12/6/2006
|
$1,112.50
|
|
Chemical Genetics in Drug Discovery
By: Decision Resources
In the drive to streamline the drug discovery process, biotechnology and pharmaceutical companies
are harnessing chemical genetics as a tool to overcome the limitations of traditional target-based drug
discovery. Although chemical genetics approaches show great
|
more...
|
11/30/2006
|
$1,112.50
|
|
Biogenerics
By: Global Industry Analysts
This report analyzes the worldwide markets for Biogenerics in US$ Million. The report provides separate comprehensive analytics for the US, Europe, and Rest of World. Annual forecasts are provided for each region for the period
|
more...
|
7/1/2006
|
$3,950.00
|
|
Biogenerics 2006: Challenges Ahead For An Emerging Market
By: Visiongain
The world biogenerics market is about to develop on a very large scale. The approval of generic growth hormones in the US and Europe has finally occurred and this has created a new source of
|
more...
|
6/14/2006
|
$2,210.00
|
|
Directed Molecular Evolution: Product Lifecycle Management For Biologics
By: Datamonitor
Introduction
Biologics are forecast to be the fastest growing segment of the pharmaceutical market out to 2010 (12.2% CAGR). However, biologics face the emergence of bio-similars and increasing numbers of competitor products, both factors that
|
more...
Search inside this report
|
5/4/2006
|
$7,600.00
|
|
DNA Market in China: An Analysis
By: RocSearch
This report examines the growing market for DNA technologies, products and services in China. It starts with an overview of the biotech market in China and goes on to explain how genetic research has spawned
|
more...
Search inside this report
|
5/1/2006
|
$1,500.00
|
|
The Market for DNA Molecular Weight Markers: Climbing the Ladder to the Top
By: BioInformatics, LLC
With nearly one hundred different types of DNA molecular weight markers available from over 20 suppliers, ensuring that one’s products are successful in the market is a challenging endeavor. Given that this product has the
|
more...
|
4/1/2006
|
$500.00
|
|
Title
|
Published
|
Price
|
(0 items)
